BioUK announced the winners of the 18th annual BioUK Awards during a ceremony at the Royal Lancaster Hotel in London. The event honored significant achievements across the life sciences sector, featuring awards in 12 categories including a Special Recognition Award.
This year, U-Ploid Biotechnologies received the Best Start-Up Biotech Company Award for their development of a first-in-class therapeutic targeting age-related infertility. The Best Emerging Biotech Company Award went to Mursla Bio, recognized for its work in Extracellular Vesicle science and its mission to enhance patient outcomes through AI precision medicine.
Calla Lily Clinical Care was awarded the Best Early Stage Medtech Company Award for their intravaginal drug-delivery platform, which addresses threatened miscarriage and IVF. The platform also has potential applications in oncology, menopause, infection, and live-biotherapeutics. Huma Therapeutics took home the Most Transformative Healthtech Company Award, praised for their AI operating system designed for regulated healthcare.
The Most Impactful Deal Award was given to Bicycle Therapeutics for establishing the world’s first end-to-end 212Pb radiopharmaceutical ecosystem, which encompasses various stages from discovery to commercial supply. Calla Lily Clinical Care also secured the BioSeed ‘One to Watch’ Award, making it a double winner for the evening.
Weatherden won the Best Industry Support Partner Award for its role in assisting biotech and pharmaceutical companies in realizing their potential. Qureight received the Most Impactful CRO Award for providing specialized imaging solutions for clinical trials, particularly in lung and heart diseases.
Digostics was recognized as the Best Established Medtech Company for launching the only home test kit capable of performing the oral glucose tolerance test, a key diagnostic tool for diabetes. The Best Established Biotech Company Award went to Sitryx Therapeutics, based in Oxford, for its innovative work in immunometabolism aimed at restoring immune balance and aiding patients with chronic autoimmune diseases.
Stephanie Annett, a senior lecturer and principal investigator at RCSI University of Medicine and Health Sciences, was named the Emerging Life Sciences Entrepreneur of the Year for her role with ImuPhile, an impending university pre-spinout company. Professor Matthew Wood received the Special Recognition Award for his contributions to the UK life sciences sector and his efforts to combat rare diseases affecting millions worldwide.
“On behalf of the BioUK community, I would like to take the opportunity to congratulate all of last night’s finalists and winners. The BioUK Awards bring together the very best of the UK life sciences, and this year’s finalists truly reflect the innovation, determination and scientific rigor that make our sector a leading voice on the global stage. Thank you to everyone who has supported this year’s program, allowing us to recognize and celebrate the amazing science that is helping to bring real benefit to patients across the world,” said Stuart Rose, CEO of BioUK.
BioUK congratulated all winners and nominees for their remarkable innovations and achievements in the life sciences.
